Search | Médecins Sans Frontières Access Campaign

326 results found

Press release |

29 November 2018

Pharmaceutical corporations failing children with HIV

MSF criticises pharma for dragging feet on developing HIV drugs for children.

Tags HIV/AIDS HIV/AIDS lopinavir/ritonavirdolutegravir CiplaMerckViiV

Vials of Amphotericin B which is used to treat Cryptococcal Meningitis, an opportunistic infection affecting very low immunity from HIV patients.

Letter |

25 July 2018

MSF Access calls on Gilead to urgently make its life-saving cryptococcal meningitis treatment more accessible and affordable

Tags HIV/AIDS cryptococcal meningitisHIV/AIDS antiretroviral medicines diagnostic testsstock out World Health OrganizationGilead

An MSF nurse performs a Cryptococcal Antigen (CrAg) screening test to test for Cryptococcal Meningitis in an AIDS patient.

Letter |

24 July 2018

MSF calls on Mylan to urgently make its life-saving cryptococcal meningitis treatment more accessible and affordable

Tags HIV/AIDS cryptococcal meningitis antiretroviral medicines opportunistic infectionsWHO pre-qualification World Health Organization

Feature story |

23 July 2018

Meeting the specific needs of key populations living with HIV – MSF’s experience

Tags HIV/AIDS hepatitis CHIV/AIDStuberculosis antiretroviral medicines access to medicines MalawiMozambiqueIndia

Issue brief |

23 July 2018

Stopping senseless deaths

This issue brief analyses access barriers to affordable, lifesaving diagnostics and treatments for HIV and OIs, including adult and paediatric formulations of dolutegravir – a highly effective and tolerable HIV integrase inhibitor that ...

Tags HIV/AIDS drug-resistant TBHIV/AIDSΚaposi's sarcomatuberculosis valganciclovirantiretroviral medicinesbedaquiline access to medicinesfree trade agreement International AIDS Conference

11 years old Gloria, is HIV and TB positive, her mother stands next to her.

Letter |

19 July 2018

MSF calls on ViiV to urgently step up efforts to ensure widespread access to dolutegravir for children

MSF and over 30 organisations signed a letter urging the company to make its medicine available to the children who need it.

Tags HIV/AIDS HIV/AIDS antiretroviral medicinesdolutegravir access to medicines ViiV

Letter |

05 December 2017

MSF urges ViiV to register its paediatric HIV drug formulation of dolutegravir broadly across low and middle income countries

Tags HIV/AIDS antiretroviral medicinesdolutegravir ViiV

Nsanje, Malawi: Simbazako, 19 years, undergoes radiography for tuberculosis in Nsanje district hospital, Malawi. He says: “I feel too much pain in my ribs. I take my ARVs without skipping even a day but my health is not improving as I had expected.”

Photo story |

25 July 2017

Photo story: Advanced HIV in the test & start era

Tags HIV/AIDS HIV/AIDS antiretroviral medicines International AIDS Conference Democratic Republic of the CongoKenyaMalawi

Report |

19 July 2017

Waiting isn't an option: Preventing and surviving advanced HIV

Tags HIV/AIDS HIV/AIDS antiretroviral medicines

Report |

17 July 2017

Putting HIV and HCV to the Test, 3rd Ed, 2017

This report is a guide for policymakers, treatment providers and advocates interested in learning more about diagnostic and monitoring tests for HIV and hepatitis C virus (HCV), including both laboratory-based and point-of-care ...